Aromatase inhibitors for ovulation induction

Journal of Clinical Endocrinology and Metabolism

Volumn 100, Issue 5, 2015, Pages 1742-1747

  Palomba, Stefano ^a  

^a ASMN IRCCS of Reggio Emilia   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANASTROZOLE; AROMATASE INHIBITOR; CLOMIFENE CITRATE; EXEMESTANE; GONADOTROPIN; LETROZOLE; FERTILITY PROMOTING AGENT;

ANENCEPHALUS; ANOVULATION; AORTA COARCTATION; ARTICLE; BLADDER EXSTROPHY; BONE MALFORMATION; CONGENITAL HEART MALFORMATION; DANDY WALKER SYNDROME; DRUG APPROVAL; DRUG COST; DRUG EFFICACY; DRUG INDICATION; DRUG POTENCY; DRUG SAFETY; DRUG TOLERABILITY; ESOPHAGUS ATRESIA; EVIDENCE BASED MEDICINE; HEART SEPTUM DEFECT; HEART VENTRICLE SEPTUM DEFECT; HUMAN; LIFESTYLE MODIFICATION; META ANALYSIS (TOPIC); MONOTHERAPY; NONHUMAN; OBESITY; OMPHALOCELE; OVARY POLYCYSTIC DISEASE; OVULATION INDUCTION; PHASE 2 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); FEMALE; PROCEDURES; TREATMENT OUTCOME;

ANOVULATION; AROMATASE INHIBITORS; FEMALE; FERTILITY AGENTS, FEMALE; HUMANS; OVULATION INDUCTION; TREATMENT OUTCOME;

EID: 84929378150     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2014-4235     Document Type: Article

References (30)

1. ESHRE Capri Workshop Group. Health and fertility in World Health Organization group 2 anovulatory women. Hum Reprod Update. 2012;18:586-599.
2. Jayasena CN, Franks S. The management of patients with polycystic ovary syndrome. Nat Rev Endocrinol. 2014;10:624-636.
3. Cakmak H, Taylor HS. Implantation failure: molecular mechanisms and clinical treatment. Hum Reprod Update. 2011;17:242-253.
4. Orio F, Palomba S. Reproductive endocrinology: new guidelines for the diagnosis and treatment of PCOS. Nat Rev Endocrinol. 2014;10:130-132.
5. Legro RS, Arslanian SA, Ehrmann DA, et al. Diagnosis and treatment of polycystic ovary syndrome: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2013;98:4565-4592.
6. Dickey RP. Strategies to reduce multiple pregnancies due to ovulation stimulation. Fertil Steril. 2009;91:1-17.
7. Bhagavath B, Carson SA. Ovulation induction in women with polycystic ovary syndrome: an update. Am J Obstet Gynecol. 2012;206:195-198.
8. Practice Committee of the American Society for Reproductive Medicine. Use of clomiphene citrate in infertile women: a committee opinion. Fertil Steril. 2013;100:341-348.
9. Thessaloniki ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Consensus on infertility treatment related to polycystic ovary syndrome. Hum Reprod. 2008;23:462-477.
10. Fields E, Chard J, James D, Treasure T. Guideline Development Group. Fertility (update): summary of NICE guidance. BMJ. 2013;346:f650.
11. Brown J, Farquhar C, Beck J, Boothroyd C, Hughes E. Clomiphene and anti-oestrogens for ovulation induction in PCOS. Cochrane Database Syst Rev. 2009;4:CD002249.
12. Legro RS, Barnhart HX, Schlaff WD, et al. Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome. N Engl J Med 2007;356:551-566.
13. Legro RS, Brzyski RG, Diamond MP, et al. Letrozole versus clomiphene for infertility in the polycystic ovary syndrome. N Engl J Med. 2014;371:119-129.
14. Dowsett M, Cuzick J, Ingle J, et al. Meta-analysis of breast cancer outcomes in adjuvant trials of aromatase inhibitors versus tamoxifen. J Clin Oncol. 2010;28:509-518.
15. Jirge PR, Patil RS. Comparison of endocrine and ultrasound profiles during ovulation induction with clomiphene citrate and letrozole in ovulatory volunteer women. Fertil Steril. 2010;93:174-183.
16. Bedaiwy MA, Abdelaleem MA, Hussein M, Mousa N, Brunengraber LN, Casper RF. Hormonal, follicular and endometrial dynamics in letrozole-treated versus natural cycles in patients undergoing controlled ovarian stimulation. Reprod Biol Endocrinol. 2011;9:83.
17. Casper RF, Mitwally MF. A historical perspective of aromatase inhibitors for ovulation induction. Fertil Steril. 2012;98:1352-1355.
18. Bao SH, Sheng SL, Peng YF, Lin QD. Effects of letrozole and clomiphene citrate on the expression of HOXA10 and integrin alpha v beta 3 in uterine epithelium of rats. Fertil Steril. 2009;91:244-248.
19. Mitwally MF, Casper RF. Aromatase inhibition: a novel method of ovulation induction in women with polycystic ovary syndrome. Reprod Technol. 2000;10:244-247.
20. Mitwally MF, Casper RF. Use of an aromatase inhibitor for induction of ovulation in patients with an inadequate response to clomiphene citrate. Fertil Steril. 2001;75:305-309.
21. Requena A, Herrero J, Landeras J, et al. Use of letrozole in assisted reproduction: a systematic review and meta-analysis. Hum Reprod Update. 2008;14:571-582.
22. Tredway DR, Schertz JC. Anastrozole versus clomiphene citrate: which is better for ovulation induction? Fertil Steril. 2011;95:1549-1551.
23. Franik S, Kremer JA, Nelen WL, Farquhar C. Aromatase inhibitors for subfertile women with polycystic ovary syndrome. Cochrane Database Syst Rev. 2014;2:CD010287.
24. Harbin Consensus Conference Workshop Group. Improving the reporting of clinical trials of infertility treatments (IMPRINT): modifying the CONSORT statement†‡. Hum Reprod. 2014;29:2075-2082.
25. Palomba S, Orio F Jr., Zullo F. What is the best first-step therapeutic approach in treating anovulatory infertility in patients with polycystic ovary syndrome? Questions that are still unanswered. Gynecol Endocrinol. 2007;23:245-247.
26. McKnight KK, Nodler JL, Cooper JJ Jr, Chapman VR, Cliver SP, Bates GW Jr. Body mass index-associated differences in response to ovulation induction with letrozole. Fertil Steril. 2011;96:1206-1208.
27. Conway G, Dewailly D, Diamanti-Kandarakis E, et al. European survey of diagnosis and management of the polycystic ovary syndrome: results of the ESE PCOS Special Interest Group's Questionnaire. Eur J Endocrinol. 2014;171:489-498.
28. Sohrabvand F, Ansari Sh, Bagheri M. Efficacy of combined metformin-letrozole in comparison with metformin-clomiphene citrate in clomiphene-resistant infertile women with polycystic ovarian disease. Hum Reprod. 2006;21:1432-1435.
29. Reefhuis J, Honein MA, Schieve LA, Rasmussen SA, National Birth Defects Prevention Study. Use of clomiphene citrate and birth defects, National Birth Defects Prevention Study, 1997-2005. Hum Reprod. 2011;26:451-457.
30. Sharma S, Ghosh S, Singh S, et al. Congenital malformations among babies born following letrozole or clomiphene for infertility treatment. PLoS One. 2014;9:e108219.